Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal cone cell | 4 studies | 42% ± 24% |
Insufficient scRNA-seq data for expression of TAFA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 85% | 35.27 | 153 / 180 | 64% | 1.97 | 276 / 430 |
| brain | 81% | 54.04 | 2138 / 2642 | 34% | 1.73 | 239 / 705 |
| adrenal gland | 50% | 142.70 | 128 / 258 | 63% | 69.55 | 145 / 230 |
| skin | 41% | 4.62 | 740 / 1809 | 68% | 6.69 | 321 / 472 |
| thymus | 73% | 18.06 | 474 / 653 | 34% | 0.94 | 205 / 605 |
| uterus | 73% | 13.76 | 124 / 170 | 24% | 1.90 | 112 / 459 |
| eye | 0% | 0 | 0 / 0 | 88% | 3.13 | 70 / 80 |
| prostate | 72% | 16.05 | 176 / 245 | 11% | 0.20 | 55 / 502 |
| breast | 46% | 9.33 | 210 / 459 | 32% | 3.17 | 360 / 1118 |
| esophagus | 34% | 4.51 | 498 / 1445 | 8% | 0.13 | 14 / 183 |
| adipose | 36% | 8.30 | 434 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 19% | 1.57 | 4 / 21 | 12% | 0.43 | 59 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 24% | 0.85 | 11 / 45 |
| stomach | 18% | 2.19 | 66 / 359 | 4% | 0.06 | 11 / 286 |
| kidney | 13% | 1.24 | 12 / 89 | 8% | 0.14 | 74 / 901 |
| lung | 8% | 0.88 | 44 / 578 | 10% | 0.34 | 115 / 1155 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.16 | 4 / 29 |
| spleen | 13% | 1.07 | 32 / 241 | 0% | 0 | 0 / 0 |
| intestine | 11% | 0.94 | 102 / 966 | 2% | 0.07 | 10 / 527 |
| pancreas | 5% | 0.40 | 16 / 328 | 4% | 0.15 | 8 / 178 |
| blood vessel | 7% | 0.60 | 92 / 1335 | 0% | 0 | 0 / 0 |
| heart | 6% | 0.50 | 54 / 861 | 0% | 0 | 0 / 0 |
| liver | 2% | 0.17 | 4 / 226 | 1% | 0.02 | 5 / 406 |
| muscle | 1% | 0.13 | 10 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 0.08 | 7 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_1903980 | Biological process | positive regulation of microglial cell activation |
| GO_1903979 | Biological process | negative regulation of microglial cell activation |
| GO_0014016 | Biological process | neuroblast differentiation |
| GO_1902692 | Biological process | regulation of neuroblast proliferation |
| GO_0005615 | Cellular component | extracellular space |
| GO_0048018 | Molecular function | receptor ligand activity |
| Gene name | TAFA3 |
| Protein name | Chemokine-like protein TAFA-3 |
| Synonyms | FAM19A3 |
| Description | FUNCTION: Plays a role in the regulation of microglia polarization. . |
| Accessions | ENST00000361886.4 [Q7Z5A8-1] Q7Z5A8 ENST00000369630.7 [Q7Z5A8-2] |